Pioglitazone Therapy Targeting Fatigue in Breast Cancer

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 23, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Breast CancerMuscle Fatigue

Interventions

DRUG

Pioglitazone 15mg

PIO 15mg orally once daily for 2 weeks

DRUG

Pioglitazone 30 mg

PIO 30mg orally once daily for 2 weeks

Trial Locations (1)

RECRUITING

West Virginia University Cancer Institute, Morgantown

All Listed Sponsors

lead

West Virginia University

OTHER